Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0010
0.0000
(0.00%)
At close: February 27 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CHMMF | -- | -- | -- | -- |
| S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Related Tickers
RAD.AX Radiopharm Theranostics Limited
0.0260
0.00%
IUGNF Imugene Limited
0.0270
+4.25%
IMU.AX Imugene Limited
0.0370
-2.63%
RADX Radiopharm Theranostics Limited
5.0000
-5.84%
VALN Valneva SE
6.75
-5.20%
CELU Celularity Inc.
1.1600
-4.92%
NRXP NRx Pharmaceuticals, Inc.
2.2700
-0.87%
MESO Mesoblast Limited
17.15
+10.36%
CAPR Capricor Therapeutics, Inc.
15.38
+6.95%
IOVA Iovance Biotherapeutics, Inc.
4.2350
-19.49%